---
title: "Suven Pharmaceuticals Posts Gains in Fiscal Q3 Consolidated Net Profit; Shares Jump 8%"
date: "2025-02-13 15:45:11"
summary: "Suven Pharmaceuticals recorded a rise in its consolidated attributable net profit rose sharply to 828.8 million Indian rupees in the fiscal third quarter ended Dec. 31, 2024, against 467.5 million rupees a year ago. Earnings per share climbed to 3.23 rupees compared with a year-ago figure of 1.84 rupees, according..."
categories:
  - "MT Newswires"
lang:
  - "en"
translations:
  - "en"
tags:
  - "MT Newswires"
menu: ""
thumbnail: ""
lead: ""
comments: false
authorbox: false
pager: true
toc: false
mathjax: false
sidebar: "right"
widgets:
  - "search"
  - "recent"
  - "taglist"
---

Suven Pharmaceuticals recorded a rise in its consolidated attributable net profit rose sharply to 828.8 million Indian rupees in the fiscal third quarter ended Dec. 31,Â 2024, against 467.5 million rupees a year ago.

Earnings per share climbed to 3.23 rupees compared with a year-ago figure of 1.84 rupees, according to a Wednesday filing to the Indian stock exchanges by the pharmaceuticals manufacturer.

Revenue from operations in fiscal Q3 also increased to 3.07 billion rupees from 2.20 billion rupees a year earlier.

Shares of the company were up nearly 8% in recent trade.

[MT Newswires](https://www.tradingview.com/news/mtnewswires.com:20250213:G2467331:0/)
